Christine A. Ciunci
Oncology
51 N. 39th Street
Pavilion For Advanced Care, First Floor
Philadelphia, PA 19104
Pavilion For Advanced Care, First Floor
Philadelphia, PA 19104
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy.
Journal: American journal of clinical oncology
Published: May 25, 2025
Late Immune-Related Adverse Events After At Least Two Years of Immune Checkpoint Inhibitor Therapy: Incidence and Association With Survival in Patients With Advanced NSCLC.
Journal: JTO clinical and research reports
Published: February 06, 2025
Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line Therapy.
Journal: Clinical lung cancer
Published: August 28, 2024
Brief Report: Long-Term Follow-Up of Adjuvant Pembrolizumab After Locally Ablative Therapy for Oligometastatic NSCLC.
Journal: JTO clinical and research reports
Published: October 03, 2023
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation.
Journal: Clinical lung cancer
Published: September 03, 2023
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression.
Journal: Clinical lung cancer
Published: June 05, 2023
Synchronous Primary Lung Cancers Containing Discrete Driver Mutations in a Never-Smoker: Case Report.
Journal: Case reports in oncology
Published: May 30, 2023
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: April 26, 2023
Brief Report: Second-line treatment outcomes in patients with advanced NSCLC previously treated with first-line immunotherapy regimens.
Journal: Clinical lung cancer
Published: March 28, 2023
A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer.
Journal: The oncologist
Published: February 14, 2023
Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health System.
Journal: Clinical lung cancer
Published: February 13, 2023
Last Updated: 09/26/2026